Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma
- 22 October 2007
- journal article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Oncology
- Vol. 12 (5), 363-368
- https://doi.org/10.1007/s10147-007-0701-y
Abstract
The prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) in the main trunk or the first branch is very poor. Radiotherapy (RT) to PVTT was followed by hepatectomy within 2 weeks. The dose used was 30–36 Gy, in 10–12 fractions, for 15–20 days. The efficacy of preoperative RT to PVTT in the main trunk or first branch was evaluated by comparing results in patients who underwent hepatectomy (group R; n = 15) with preoperative RT and those without preoperative RT (group N; n = 28). The 1-, 3-, and 5-year survival rates in group R were 86.2%, 43.5%, and 34.8%, respectively, while these values in group N were 39.0%, 13.1%, and 13.1%, respectively. The survival curve of group R was significantly better than that of group N (P = 0.0359). In group R, five (83.3%) of six patients whose tumor thrombus was completely necrosed (based on pathological examination) and whose follow-up period was over 2 years survived for more than 2 years. Female sex (P = 0.0066), multiple tumors (P = 0.0369), and absence of preoperative RT (P = 0.0359) were ranked as significant factors for a poor prognosis by univariate analysis. Multivariate analysis revealed absence of preoperative RT and female sex to be significant factors for a poor prognosis. Preoperative RT to PVTT in the main trunk or first branch improved the prognosis of patients with HCC with PVTT, and could be a promising new modality in the treatment of these patients.Keywords
This publication has 29 references indexed in Scilit:
- Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinomaEuropean Journal of Surgical Oncology, 2006
- AFP mRNA Detected in Bone Marrow by Real-Time Quantitative RT-PCR Analysis Predicts Survival and Recurrence After Curative Hepatectomy for Hepatocellular CarcinomaAnnals of Surgery, 2006
- Treatment of Portal Vein Tumor Thrombosis of Hepatoma Patients with Either Stereotactic Radiotherapy or Three-Dimensional Conformal RadiotherapyJapanese Journal of Clinical Oncology, 2006
- Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosisCancer, 2002
- Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosisJournal of the American College of Surgeons, 2000
- Surgical Intervention for Patients With Stage IV-A Hepatocellular Carcinoma Without Lymph Node MetastasisAnnals of Surgery, 1998
- The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstructionCancer, 1997
- Is Preoperative Hepatic Arterial Chemoembolization Safe and Effective for Hepatocellular Carcinoma?Annals of Surgery, 1996
- Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.American Journal of Roentgenology, 1995
- Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomyCancer, 1992